Johnson & Johnson lowers 2026 profit forecast

J&J lowers 2026 profit forecast on deal costs, sees further hit in 2027 - Regional Media News

July 29 (Reuters) - Johnson & Johnson cut 2026 profit forecast on Wednesday, citing the combined financial impact of its newly completed acquisition of Firefly Bio and a strategic partnership with Sail Biomedicines. The healthcare giant expects full-year adjusted earnings per share of $10.96 to $11.11, compared with its previous forecast of $11.60 to $11.75. Its shares were down 1.6% in extended trading. The two transactions are expected to redu…

Johnson & Johnson lowers 2026 profit forecast

July 29 (Reuters) - Johnson & Johnson cut ​2026 ‌profit forecast on Wednesday, citing ‌the ​combined ⁠financial impact ⁠of its newly completed acquisition of ​Firefly Bio ⁠and ⁠a strategic ​partnership with ​Sail Biomedicines. The healthcare ‌giant exp...